PSMA-PET imaging for guiding radiation therapy in prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This study tests a new way to use a PSMA-PET scan (a special imaging test that finds prostate cancer cells) to guide a type of radiation treatment called BgRT. It is for men with prostate cancer who are already getting a PSMA-PET scan as part of their regular care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have prostate cancer that has been confirmed by a doctor.
- You should be scheduled for a PSMA-PET scan as part of your regular cancer care.
- You must weigh less than 450 pounds (about 204 kilograms).
- You cannot have a serious, uncontrolled medical condition (like an active infection, severe heart failure, or unstable chest pain).
- You cannot have a psychiatric or substance abuse problem that would make it hard to follow the study rules.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special PET/MR scan to help doctors aim stereotactic radiation more precisely for certain higher-risk or unfavorable intermediate prostate cancers. It studies whether this targeted approach can safely treat the prostate (and specific areas needing extra treatment) without spreading to the body.
This trial tests whether a special PET scan (called PSMA, which pictures prostate cancer cells) can help doctors better find any remaining or spread of prostate cancer when your PSA level is rising again. It's for people who are planning radiation therapy, and the goal is to see if the scan changes the treatment plan.
This Phase 3 study checks whether a PSMA PET/CT scan (using a special tracer) can help doctors make better decisions for people with prostate cancer after treatment, based on PSA blood test changes. It may help identify whether cancer has spread or how to plan next steps.
This study tests whether using a special PET scan (PSMA PET/CT) to guide prostate biopsy can help find cancer more accurately and in real time. It might help men who need a biopsy because of high PSA levels or abnormal MRI results.
This trial tests whether a special scan (PSMA PET) can help doctors aim and adjust radiation more precisely when prostate cancer returns after surgery. It may help by increasing dose to areas that look involved while lowering dose to uninvolved pelvic areas.
This early-phase study tests a precise, targeted radiation treatment for prostate cancer, using a special PET scan to help plan exactly where to treat. It may help reduce the amount of radiation to surrounding tissues while treating the cancer.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.